SheMed Built a $1 Billion Business on GLP-1s. Its Next Bet Goes Beyond Weight Loss
SheMed’s study of more than 8,000 women found improvements in weight, blood sugar, and cholesterol. Its founders believe that’s just the start of what GLP-1 research could uncover.
⬅ Back home Read full article ➡